Letters, Statements & Analysis (2019)
Communicating the importance of managed care pharmacy is a key part of AMCP’s work. Using AMCP policies as a basis for their work, AMCP staff and volunteers provide comments, analysis and testimony to Congress and other federal and state agencies on how proposed regulations and laws impact managed care pharmacy and the patients we serve.
December
12/16/2019
AMCP submits comments to U.S. House of Representative on 21st Century Cures 2.0
October
10/25/2019
August
8/16/2019
8/12/2019
July
7/24/2019
June
6/3/2019
6/3/2019
May
5/31/2019
5/18/2019
5/7/2019
April
4/8/2019
4/3/2019
March
3/1/2019
February
2/28/2019
2/18/2019
AMCP summary: Food and Drug Administration (FDA) Definition of the Term “Biological Product”
2/12/2019
2/06/2019
2/05/2019
January
1/30/2019
1/28/2019
1/25/2019